Defiance Daily Target 2X Long MRNA ETF(MRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNX Defiance Daily Target 2X Long MRNA ETF

盘前交易 06-18 08:50:27 EDT

34.11

+5.44

+18.97%

盘前34.88

+0.26+0.75%

08:46 EDT

最高36.06	最低27.01	成交量3.12万
今开27.01	昨收28.67	日振幅31.55%
总市值375.21万	流通市值375.21万	总股本11.00万
成交额97.95万	换手率28.33%	流通股本11.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":34.11,"timestamp":1781726400000,"preClose":28.6713,"halted":0,"volume":31160,"hourTrading":{"tag":"盘前","latestPrice":34.8785,"preClose":34.62,"latestTime":"08:46 EDT","volume":4726,"amount":166379.7752,"timestamp":1781786780820,"change":0.2585,"changeRate":0.007467,"amplitude":0.056904},"delay":0,"changeRate":0.18969143359387267,"floatShares":110000,"shares":110000,"eps":0,"marketStatus":"盘前交易","change":5.4387,"latestTime":"06-18 08:50:27 EDT","open":27.01,"high":36.055,"low":27.01,"amount":979468.639,"amplitude":0.315472,"askPrice":40,"askSize":2,"bidPrice":34.67,"bidSize":20,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781789400000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":34.62,"sharesOutstanding":30000,"nav":27.85,"aum":3063500,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.8785,"preClose":34.62,"latestTime":"08:46 EDT","volume":4726,"amount":166379.7752,"timestamp":1781786780820,"change":0.2585,"changeRate":0.007467,"amplitude":0.056904},"postHourTrading":{"tag":"盘后","latestPrice":33.48,"preClose":34.11,"latestTime":"19:56 EDT","volume":940,"amount":32066.435,"timestamp":1781740566725,"change":-0.63,"changeRate":-0.01847,"amplitude":0.026678},"volumeRatio":1.8317838316801445},"requestUrl":"/m/hq/s/MRNX","defaultTab":"news","newsList":[{"id":"1179067083","title":"FDA工作人员初步评估：Moderna流感疫苗数据或支持65岁及以上成人有效性","url":"https://stock-news.laohu8.com/highlight/detail?id=1179067083","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179067083?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:49","pubTimestamp":1781614183,"startTime":"0","endTime":"0","summary":"根据一份文件披露，美国食品药品监督管理局（FDA）工作人员已完成初步评估。其结论指出，Moderna公司提交的流感疫苗数据，可能为证明该疫苗对65岁及以上成年人群的有效性提供支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4501","MRNY","BK4532","BK4534","BK4585","BK4568","BK4548","MRNA","BK4588","BK4533","MRNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124334353","title":"Moderna组织架构调整 为2027及2028年多款产品上市铺路","url":"https://stock-news.laohu8.com/highlight/detail?id=1124334353","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124334353?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:48","pubTimestamp":1781614130,"startTime":"0","endTime":"0","summary":"Moderna, Inc. 正着手进行一系列组织架构调整，旨在为2027年和2028年可能推出的多款新产品做好充分准备。公司预计，在这两年内，有望上市多达三款新疫苗，其中包括一款流感与新冠二合一疫苗、季节性流感疫苗以及诺如病毒疫苗。为了支持这一雄心勃勃的商业化蓝图，Moderna已任命埃斯特·班克为公司首席商务官，该任命自2026年6月15日起生效。这些战略举措清晰地勾勒出Moderna为即将到来的产品上市浪潮所做的系统性准备。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4585","BK4501","BK4534","MRNX","BK4139","BK4533","BK4532","BK4551","BK4588","MRNA","BK4548","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169654490","title":"Moderna任命Ester Banque为首席商务官，2026年6月15日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1169654490","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169654490?lang=zh_cn&edition=full","pubTime":"2026-06-16 19:33","pubTimestamp":1781609595,"startTime":"0","endTime":"0","summary":"Moderna, Inc. 宣布，已任命Ester Banque为公司首席商务官，此项任命自2026年6月15日起正式生效。作为首席商务官，Banque将全面负责公司的全球商业战略、市场准入及销售运营，领导团队推动公司产品组合的商业化进程。此次高层人事变动旨在加强Moderna在全球商业运营方面的领导力，以应对不断变化的市场环境并把握未来的增长机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4533","MRNX","BK4548","MRNY","BK4568","BK4588","BK4534","BK4532","MRNA","BK4551","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155700158","title":"Moderna总裁斯蒂芬·霍格扩大职责范围，将负责传染病、Intismeran及罕见病业务板块的运营监督","url":"https://stock-news.laohu8.com/highlight/detail?id=1155700158","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155700158?lang=zh_cn&edition=full","pubTime":"2026-06-16 19:33","pubTimestamp":1781609594,"startTime":"0","endTime":"0","summary":"Moderna公司宣布，其总裁斯蒂芬·霍格将承担更广泛的职责，负责监督公司传染病业务、Intismeran以及罕见病业务板块的运营工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","MRNY","BK4551","BK4533","BK4588","BK4568","BK4585","BK4548","BK4534","MRNA","BK4139","BK4532","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100185800","title":"Moderna获CEPI高达5000万美元资助，用于推进BDBV候选疫苗临床前研发与一期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1100185800","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100185800?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:03","pubTimestamp":1780304598,"startTime":"0","endTime":"0","summary":"Moderna, Inc. 宣布，流行病防范创新联盟（CEPI）已承诺提供高达5000万美元的资金，以支持该公司针对布尼亚病毒科（Bunyavirales）的候选疫苗的临床前开发及一期临床试验。\n这笔重要的资金注入将加速该研究性疫苗的研发进程，涵盖从实验室研究到初步人体安全性与免疫反应评估的关键阶段。Moderna将利用其在mRNA技术平台上的专业优势，推进这一针对潜在公共卫生威胁的预防性疫苗的开发工作。\n此次合作凸显了全球卫生组织与生物技术公司携手应对新兴传染病威胁的共同努力。资金的到位为候选疫苗的早期研发提供了关键资源，有望推动其向更广泛的临床测试阶段迈进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","BK4585","BK4568","BK4548","BK4534","MRNY","MRNX","BK4588","BK4551","BK4501","MRNA","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139235440","title":"美国FDA顾问投票支持建议2026-27年度新冠疫苗以Jn.1谱系Xfg变异株为靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=1139235440","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139235440?lang=zh_cn&edition=full","pubTime":"2026-05-29 02:28","pubTimestamp":1779992883,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局的疫苗顾问小组已投票支持一项建议，即在2026-2027年度的新冠疫苗接种活动中，应将疫苗的靶点更新为当前流行的Jn.1谱系Xfg变异株。这一决定标志着公共卫生机构在应对病毒持续演变方面迈出了关键一步。相关企业可能需要据此调整其疫苗成分，以符合新的公共卫生指导。随着病毒变异，疫苗的定期更新已成为新常态，以确保其防护效力。最终决定权仍在FDA，但通常其会采纳顾问委员会的建议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","BK4533","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999002232.USD","BK4532","IE00BBT3K403.USD","BK4599","LU0234572021.USD","BK4581","NVAX","SG9999002224.SGD","LU0225284248.USD","BK4139","BK4548","IE00B19Z3581.USD","SG9999003800.SGD","MRNA","IE000M9KFDE8.USD","BK4547","LU0321505868.SGD","LU0122379950.USD","LU1023059063.AUD","SGXZ57979304.SGD","SG9999001176.USD","IE00BLSP4239.USD","MRNY","LU1883839398.USD","BK4568","BK4588","SG9999001176.SGD","IE00B3T34201.USD","SG9999013999.USD","BK4007","LU0306806265.USD","LU0985481810.HKD","SG9999011175.SGD","BK4501","IE0002270589.USD","LU0306807586.USD","BK4585","LU1894683264.USD","LU1894683348.USD","MRNX","BK4550","BK4592","LU1057294990.SGD","LU0868494617.USD","LU0289739699.SGD","LU0456855351.SGD","LU0058720904.USD","PFE","BK4534","LU0225771236.USD","LU0321505439.SGD","BK4551","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158347106","title":"Moderna公司计划于八月中旬前备妥2026-27年度推荐新冠疫苗组分供应","url":"https://stock-news.laohu8.com/highlight/detail?id=1158347106","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158347106?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:19","pubTimestamp":1779970758,"startTime":"0","endTime":"0","summary":"根据最新简报文件披露，Moderna公司已做好充分准备，预计将在八月中旬之前完成针对2026-27年度推荐新冠疫苗组分的生产供应部署。这一时间节点对于确保秋季疫苗接种计划的顺利推进具有关键意义，显示出该公司在应对公共卫生需求方面的前瞻性布局能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4501","BK4533","BK4139","MRNX","MRNY","MRNA","BK4548","BK4585","BK4534","BK4588","BK4551","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143160264","title":"个股聚焦：Moderna、英特尔、MidCap Financial Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=1143160264","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143160264?lang=zh_cn&edition=full","pubTime":"2026-05-11 17:46","pubTimestamp":1778492797,"startTime":"0","endTime":"0","summary":"Moderna  股价在盘前交易中飙升了8%。此前，这家生物医药公司向媒体透露，早在近期一艘邮轮爆发疫情之前，他们就已经启动了针对汉坦病毒的疫苗研发工作。市场对人工智能相关企业的热情持续高涨，推动这两家芯片制造商的股价双双上扬。就在上周五，它们的收盘价均创下了历史新高。据消息，阿波罗全球管理  已就出售其上市业务发展公司 MidCap Financial Investment Corp  进行了谈判。福克斯-A  则是今日计划公布财报的公司之一。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c3eded8fb3ee9cd51304c05def1e555f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4529","BK4535","LU0127658192.USD","INTW","BK4551","BK4527","BK4543","APO","LU2250418816.HKD","LU0321505439.SGD","BK4501","LU1267930813.SGD","MULL","LU0056508442.USD","LU0792757196.USD","LU0889565833.HKD","LU2458330243.SGD","LU1316542783.SGD","LU0321505868.SGD","BK4568","IE0009356076.USD","LINT","IE00B19Z3B42.SGD","BK4533","MRNA","BK4605","BK4575","LU2211815571.USD","IE00B19Z3581.USD","BK4512","LU0081259029.USD","LU0203345920.USD","LU0274383776.USD","IE000M9KFDE8.USD","IE0002270589.USD","LU2458330169.SGD","MRNY","INTC","BK4125","04335","BK4585","MUU","IE00B7SZLL34.SGD","LU0109392836.USD","LU1852331112.SGD","MU","BK4602","LU0154236417.USD","LU2089985449.USD","IE00B5949003.HKD","LU0203347892.USD","FOXA","LU0719512351.SGD","BK4532","GB00BDT5M118.USD","BK4612","BK4554","LU0157215616.USD","BK4135","BK4550","LU1803068979.SGD","BK4141","LU1323610961.USD","LU2054465674.USD","LU0082616367.USD","MRNX","LU0097036916.USD","BK4534","LU0642271901.SGD","BK4553","MFIC","BK4515","LU2286300806.USD","LU0889566641.SGD","BK4588","BK4566","BK4139","LU1366333091.USD","BK4548","MUD","LU2148611432.USD","LU2543165471.USD","LU2931357623.SGD","BK4579","LU2360106780.USD","LU2048586759.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144457907","title":"Moderna股价大涨逾10%，此前其公布mRNA汉坦病毒疫苗一期临床积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1144457907","media":"老虎资讯综合","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144457907?lang=zh_cn&edition=full","pubTime":"2026-05-08 23:14","pubTimestamp":1778253284,"startTime":"0","endTime":"0","summary":"Moderna周五早盘股价上涨超10%，此前公司公布了其mRNA汉坦病毒疫苗的一期临床积极数据。这一进展重新提振了投资者对Moderna mRNA产品管线的信心。对于Moderna而言，这项数据验证了其mRNA平台应对多种病毒疾病的能力。汉坦病毒一期数据及其对Moderna mRNA平台的意义Moderna针对其研究性汉坦病毒疫苗候选产品开展的一期临床研究显示，该疫苗耐受性良好，未出现严重安全性信号，并在所有剂量组中均诱导出强劲的抗体反应。","market":"us","thumbnail":"https://community-static.tradeup.com/news/fad861c5b82ebcd2a29c6ff47f3e0a8b","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/fad861c5b82ebcd2a29c6ff47f3e0a8b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7c550214a914aa5b0d6e74a203b21919","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Moderna公布mRNA汉坦病毒疫苗一期临床积极数据","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","MRNA","MRNX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2633459715","title":"中慧生物-B(02627)：中国药审中心批准MRNA RSV疫苗IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459715","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633459715?lang=zh_cn&edition=full","pubTime":"2026-05-08 20:57","pubTimestamp":1778245029,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，继集团于2025年11月7日获美利坚合众国食品药品监督管理局批准其于美国提交的新药临床试验申请后，国家药品监督管理局药品审评中心已批准集团自主研发的mRNA RSV疫苗候选产品的IND申请。目前在中国，RSV感染的治疗仍依赖广谱抗病毒药物及对症治疗。因此，迫切需要开发一种有效的RSV疫苗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","BK4534","IND","BK4501","BK4139","BK4588","BK4551","BK4585","BK1161","MRNY","BK4532","MRNX","MRNA","BK4548","BK4568","02627","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167020721","title":"Moderna 的 mRNA 流感疫苗在后期试验中表现优于标准疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1167020721","media":"老虎资讯综合","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167020721?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:46","pubTimestamp":1778157971,"startTime":"0","endTime":"0","summary":"如果获批，Moderna 的疫苗将成为美国首款采用 mRNA 技术制成的季节性流感疫苗。研究人员表示，两组之间严重副作用发生率基本相当：接种 mRNA 疫苗的人群中为 2.2%，而接种标准剂量疫苗的人群中为 1.9%。今年 2 月，FDA 曾拒绝 Moderna 的申请，原因是对照组所使用的标准剂量流感疫苗存在争议。目前，Moderna 的流感疫苗也正在欧盟、加拿大和澳大利亚接受监管审查。","market":"us","thumbnail":"https://community-static.tradeup.com/news/fad861c5b82ebcd2a29c6ff47f3e0a8b","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/fad861c5b82ebcd2a29c6ff47f3e0a8b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9f673a7486b2730831727fea6d8ee170","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Moderna 的 mRNA 流感疫苗在后期试验中表现优于标准疫苗","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","MRNY","MRNX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1150823990","title":"Moderna高管称公司正等待FDA指导 以恢复流感-新冠联合疫苗美国申报流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1150823990","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150823990?lang=zh_cn&edition=full","pubTime":"2026-05-01 20:24","pubTimestamp":1777638268,"startTime":"0","endTime":"0","summary":"Moderna公司高管近日表示，该公司正在等待美国食品药品监督管理局的进一步指导，以确定恢复流感与新冠联合疫苗在美国申报的后续步骤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4501","BK4532","MRNX","MRNY","BK4548","BK4588","BK4533","BK4534","MRNA","BK4585","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104357139","title":"Moderna公布第一季度每股亏损3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104357139","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104357139?lang=zh_cn&edition=full","pubTime":"2026-05-01 18:54","pubTimestamp":1777632878,"startTime":"0","endTime":"0","summary":"Moderna公司最新财报显示，第一季度营收达到3.89亿美元，远超华尔街分析师预期的2.28亿美元。尽管营收表现亮眼，公司当季每股亏损为3.40美元，略好于市场预估的每股亏损3.96美元。展望未来，Moderna预计将在2026年恢复销售增长态势，并有望获得包括季节性流感疫苗在内的多项新批准。财务储备方面，Moderna预计到2026年底，现金及投资规模将保持在45亿至50亿美元区间，为后续研发和市场拓展提供有力支撑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4588","BK4551","MRNY","BK4534","MRNA","BK4533","BK4548","BK4532","BK4585","MRNX","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131327497","title":"Moderna预计2026年恢复销售增长 将获多项新批准含季节性流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1131327497","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131327497?lang=zh_cn&edition=full","pubTime":"2026-05-01 18:31","pubTimestamp":1777631481,"startTime":"0","endTime":"0","summary":"生物技术公司Moderna, Inc.近日宣布，公司预计将在2026年重返销售增长轨道。这一乐观预测基于其研发管线中多个候选药物即将获得的监管批准，其中包括备受关注的季节性流感疫苗。\nModerna管理层表示，除了流感疫苗外，公司还预期在2026年前获得其他几项重要产品的上市许可。这些新产品的陆续获批将为公司注入新的增长动力，帮助其扭转近期销售额下滑的局面。\n该公司强调，其在mRNA技术平台的持续投入正在进入收获期，未来将通过多元化产品组合推动业绩回升。市场分析师认为，若这些预期顺利实现，Moderna有望重新确立其在疫苗领域的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5c970505340e4afbf29108a4480b7217","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4533","MRNX","BK4548","MRNY","BK4568","BK4588","BK4534","BK4532","MRNA","BK4551","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137525165","title":"赛富时推出互联平台，整合多区域商业用户的数据、人工智能与客户互动","url":"https://stock-news.laohu8.com/highlight/detail?id=1137525165","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137525165?lang=zh_cn&edition=full","pubTime":"2026-04-28 21:08","pubTimestamp":1777381710,"startTime":"0","endTime":"0","summary":"赛富时宣布，其全新互联平台将实现跨多个地区的商业用户在数据管理、人工智能应用以及客户互动方面的无缝整合。该平台旨在通过统一的技术架构，帮助企业更高效地利用数据资源、部署智能算法，并优化客户参与流程，从而提升整体运营效能与市场响应速度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","LU1791710400.SGD","LU1720051108.HKD","LU0648000940.SGD","LU2361044949.HKD","LU2247934214.USD","LU1046421795.USD","BK4567","IE00BJTD4N35.SGD","LU1791710582.SGD","BK4538","LU0820562030.AUD","LU2087625088.SGD","BK4139","LU2756315318.SGD","LU0048573561.USD","BK4527","LU1201861165.SGD","LU0211328371.USD","LU0109392836.USD","LU0251142724.SGD","LU1267930490.SGD","BK4532","LU0251131958.USD","IE00B19Z8W00.USD","LU0792757196.USD","LU1496350502.SGD","LU2357305700.SGD","LU2756315664.SGD","IE00BQXX3D17.EUR","LU1201861249.SGD","LU0689472784.USD","LU0353189763.USD","LU2265009873.SGD","LU0198837287.USD","LU2286300806.USD","BK4585","BK4598","LU0069063385.USD","IE00BQXX3F31.USD","LU0648001328.SGD","LU0289739343.SGD","LU0130518102.USD","LU1823568750.SGD","LU0557290698.USD","LU2236285917.USD","LU0742534661.SGD","LU1267930813.SGD","BK4534","BK4613","LU0157215616.USD","LU1951200564.SGD","LU0472753341.HKD","LU0106261372.USD","LU0353189680.USD","IE00B19Z8X17.USD","LU2458330243.SGD","LU0889566641.SGD","BK4579","LU0187121727.USD","LU1951198990.SGD","LU0528227936.USD","LU0354030438.USD","LU0234572021.USD","LU2361045086.USD","LU2361044865.SGD","LU1548497426.USD","LU2461242641.AUD","BK4607","BK4543","BK4535","LU0127658192.USD","LU0130102774.USD","BK4533","LU0057025933.USD","LU0234570918.USD","BK4528","LU0238689110.USD","LU0289961442.SGD","LU0267386448.USD","BK4581","CRMG","CRM","LU0889565833.HKD","LU0477156797.USD","LU1923623000.USD","LU1316542783.SGD","LU0082616367.USD","MRNX","LU1366333091.USD","LU1988902786.USD","LU0130103400.USD","BK4550","LU0719512351.SGD","IE00BZ1G4Q59.USD","LU1720051017.SGD","BK4561","LU1551013342.USD","LU1989764664.SGD","LU0006306889.USD","LU2458330169.SGD","LU2244417387.USD","IE00BKVL7J92.USD","LU1235294995.USD","LU1804176565.USD","LU0310799852.SGD","LU0689626769.HKD","LU1496350171.SGD","BK4568","LU1803068979.SGD","IE00BJTD4V19.USD","LU0081259029.USD","LU1551013425.SGD","LU2264538146.SGD","IE00BQXX3C00.GBP","LU0211327993.USD","LU0980610538.SGD","BK4505","LU0820561818.USD","BK4548","LU0477156953.USD","LU1989764748.USD","BK4608","LU0511384066.AUD","BK4551","BK4588","LU0943347566.SGD","LU1064131342.USD","IE00B19Z9505.USD","LU0354030511.USD","LU0642271901.SGD","LU0130517989.USD","BK4501","LU1814569148.SGD","BK4023","LU0124676726.USD","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146538586","title":"Moderna获欧盟批准上市Mcombriax——全球首款mRNA流感与新冠联合疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1146538586","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146538586?lang=zh_cn&edition=full","pubTime":"2026-04-21 21:46","pubTimestamp":1776779188,"startTime":"0","endTime":"0","summary":"生物技术巨头Moderna, Inc.宣布，其研发的mRNA联合疫苗Mcombriax已正式获得欧盟委员会的市场营销授权。该疫苗是全球首个采用mRNA技术同时针对流感和COVID-19的联合疫苗，标志着传染病预防领域取得重大突破。\n此次授权为欧盟成员国接种Mcombriax铺平道路，有望简化疫苗接种流程，提升公共卫生防护效率。Moderna的创新疫苗技术平台再次展现其应对复杂病毒威胁的潜力。\n业界分析指出，此次获批将强化Moderna在欧洲疫苗市场的竞争地位，并为其他多价疫苗研发提供重要参考。随着秋冬呼吸道疾病高发季临近，联合疫苗的市场需求预计将持续增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4532","MRNX","BK4501","MRNY","BK4551","BK4533","BK4568","BK4585","MRNA","BK4548","BK4588","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618973837","title":"莫德纳盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618973837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618973837?lang=zh_cn&edition=full","pubTime":"2026-03-11 23:09","pubTimestamp":1773241765,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日23时09分，莫德纳股票出现波动，股价快速上涨5.04%。截至发稿，该股报57.75美元/股，成交量250.671万股，换手率0.63%，振幅5.35%。莫德纳股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Acurx Pharmaceuticals, Inc.、天演药业、Ocugen, Inc.涨幅较大，Acurx Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Quince Therapeutics, Inc.较为活跃，换手率分别为1506.86%、1019.35%、62.59%，振幅较大的相关个股有Acurx Pharmaceuticals, Inc.、Kala Bio, Inc.、天演药业，振幅分别为58.62%、50.19%、41.98%。截至 2025 年 8 月，莫德纳有 35 种 mRNA 开发候选药物处于临床研究中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603112309259548dd23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603112309259548dd23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4532","BK4534","BK4501","BK4548","BK4568","BK4533","MRNY","BK4551","BK4585","MRNA","MRNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1199935387","title":"Moderna将于2026年7月8日前向Arbutus/Genevant支付9.5亿美元无条件一次性款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1199935387","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199935387?lang=zh_cn&edition=full","pubTime":"2026-03-05 19:10","pubTimestamp":1772709057,"startTime":"0","endTime":"0","summary":"生物技术巨头Moderna, Inc.宣布，其已承诺在2026年7月8日或之前，向合作方Arbutus Biopharma及其子公司Genevant Sciences支付一笔总额高达9.5亿美元的无条件一次性款项。此次支付不附带任何后续条件，标志着双方在相关技术平台合作上的一个重要财务里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4534","BK4588","BK4533","BK4139","BK4551","BK4568","BK4532","MRNX","BK4548","BK4585","MRNA","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144697251","title":"ETF日报｜三倍做多半导体ETF涨近6%；纳指三倍做多ETF涨超4%；加密与半导体产品相对跑赢","url":"https://stock-news.laohu8.com/highlight/detail?id=1144697251","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144697251?lang=zh_cn&edition=full","pubTime":"2026-03-05 09:12","pubTimestamp":1772673133,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5$2倍做多GEMI ETF-Leverage Shares$上涨65.93%。该产品两倍做多Galaxy Digital，因公司股价上涨，杠杆效应放大当日涨幅。大盘指数ETF涨幅Top 5$纳指三倍做多ETF$上涨4.49%。$三倍做多MSCI新兴市场ETF-Direxion$上涨2.92%。该产品三倍做多美国小盘股指数，指数当日上行使杠杆产品录得涨幅。该产品三倍做多半导体板块，芯片股集体走强推动杠杆产品上行。该产品配置不动产优先股，相关资产价格上行推动产品上涨。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d8aa0ef7daa8f62604f5dfb5c1b0be1b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FAS","UPXI","ASTN","LU1861558580.USD","BK4112","SRLN","BKLN","UGL","IYZ","BK4588","LU1861559042.SGD","MRNA","BK4554","BK4600","MRNX","GEMG","MSTR","BK4539","CWB","IREN","BK4595","BK4596","BK4535","LU2360107671.USD","SMST","SOXL","TNA","XLY","LU1861220207.SGD","TQQQ","ASTS","UCO","BK4550","QLD","GEMI","NBIZ","BK4516","PFFR","GLXY","AGQ","IREZ","PXIU","GLXU","BK4585","SMH","BK4551","LU1861217088.USD","ICVT","GLGG","CONI","USO","EWP","COIN","NBIS","EDC","DGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616559787","title":"莫德纳(MRNA)股价上涨14%，创2024年11月以来盘中新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2616559787","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616559787?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:44","pubTimestamp":1772635499,"startTime":"0","endTime":"0","summary":"莫德纳(MRNA)股价上涨14%，创2024年11月以来盘中新高","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603043662053278.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603043662053278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","MRNX","BK4139","BK4534","BK4533","BK4568","BK4551","BK4548","BK4585","BK4501","MRNY","MRNA","BK4532"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.7492},{"period":"1month","weight":0.5357},{"period":"3month","weight":0.1996},{"period":"6month","weight":0.655},{"period":"ytd","weight":0.655}],"compareEarnings":[{"period":"1week","weight":0.0214},{"period":"1month","weight":0.0031},{"period":"3month","weight":0.123},{"period":"6month","weight":0.0887},{"period":"1year","weight":0.24},{"period":"ytd","weight":0.0866}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"ARCA","name":"Defiance Daily Target 2X Long MRNA ETF","nameEN":"Defiance Daily Target 2X Long MRNA ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Defiance Daily Target 2X Long MRNA ETF(MRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Defiance Daily Target 2X Long MRNA ETF(MRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Defiance Daily Target 2X Long MRNA ETF,MRNX,Defiance Daily Target 2X Long MRNA ETF股票,Defiance Daily Target 2X Long MRNA ETF股票老虎,Defiance Daily Target 2X Long MRNA ETF股票老虎国际,Defiance Daily Target 2X Long MRNA ETF行情,Defiance Daily Target 2X Long MRNA ETF股票行情,Defiance Daily Target 2X Long MRNA ETF股价,Defiance Daily Target 2X Long MRNA ETF股市,Defiance Daily Target 2X Long MRNA ETF股票价格,Defiance Daily Target 2X Long MRNA ETF股票交易,Defiance Daily Target 2X Long MRNA ETF股票购买,Defiance Daily Target 2X Long MRNA ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Defiance Daily Target 2X Long MRNA ETF(MRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Defiance Daily Target 2X Long MRNA ETF(MRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}